Story at-a-glance 

Conflicts of interests at Institute of Medicine (IOM) may have coaxed the US Food and Drug Administration (FDA) to approve a new narcotic painkiller, Zohydro

When FDA Commissioner Margaret Hamburg was criticized for the agency’s approval of Zohydro, she countered saying that “100 million Americans” Continue reading →